Theo-24
NDC 52244-200, theophylline anhydrous, capsule, extended release, from ENDO USA, Inc..
- Product NDC
- 52244-200
- Status
- Listed
- Labeler
- ENDO USA, Inc.
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA087943
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52244-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- THEOPHYLLINE ANHYDROUS200 mg/1
Pharmacologic classes
Methylxanthine [EPC]; Xanthines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52244-200-10 | 52244020010 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52244-200-10) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/7a108fa0-c230-475f-be93-6f864b98a410NADAC price for package 52244020010
GET /v1/drugs/nadac/52244020010
Use it
Look up 52244-200 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52244-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52244-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.